Day: January 24, 2024

Lexaria Releases Annual Letter from the CEO

KELOWNA, BC / ACCESSWIRE / January 24, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX),(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to provide this annual letter from CEO Chris …

Read More